Ocean Biomedical Files Q1 2025 10-Q
Ticker: OCEA · Form: 10-Q · Filed: May 15, 2025 · CIK: 1869974
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: OCEA
TL;DR
OCEA 10-Q filed for Q1 2025. Financials and operations update.
AI Summary
Ocean Biomedical, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Aesther Healthcare Acquisition Corp., is involved in the pharmaceutical preparations industry. Its principal executive offices are located at 515 Madison Ave, Suite 8078, New York, NY 10022.
Why It Matters
This filing provides investors with an update on Ocean Biomedical's financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information and disclosures that could impact investor decisions, warranting a medium risk level.
Key Numbers
- 20250331 — Period End Date (The filing covers the financial period ending on this date.)
- 20250515 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Ocean Biomedical, Inc. (company) — Filer
- Aesther Healthcare Acquisition Corp. (company) — Former company name
- 20250331 (date) — Period of report
- 515 MADISON AVE SUITE 8078 (address) — Business address
- New York, NY 10022 (address) — Business address city, state, zip
FAQ
What is the primary business of Ocean Biomedical, Inc.?
Ocean Biomedical, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was the company formerly known as Aesther Healthcare Acquisition Corp.?
The company changed its name from Aesther Healthcare Acquisition Corp. on 20210628.
What is the fiscal year end for Ocean Biomedical, Inc.?
The fiscal year end for Ocean Biomedical, Inc. is December 31 (1231).
What is the business address of Ocean Biomedical, Inc.?
The business address is 515 Madison Ave, Suite 8078, New York, NY 10022.
What is the SEC file number for Ocean Biomedical, Inc.?
The SEC file number for Ocean Biomedical, Inc. is 001-40793.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Ocean Biomedical, Inc. (OCEA).